Sherida R. Vandiver, MBA, BS Vice President, Quality
With over 40 years of experience in the pharmaceutical industry, Sherida R. Vandiver serves as vice president of quality for Recro. She oversees all quality-related activities, including raw material and finished product release, internal and external audits, annual product review, validation, document control, and change control management.
Sherida has worked at the Gainesville site since 2001, experiencing the site’s progression from Elan Drug Technologies to Alkermes in 2011 and finally to Recro in 2015. While at Recro, she has been instrumental in establishing and maintaining a high level of site compliance while building a proven track record with the FDA, foreign health ministries, the DEA, and the site’s development, clinical, and commercial clients.
Previously, Sherida was director of quality assurance at Dura Pharmaceuticals, and she has also worked in various quality-related roles at Ligand Pharmaceuticals, Central Pharmaceuticals, and Bristol-Myers Squibb. She earned a Master of Business Administration from the University of Evansville and a Bachelor’s Degree in chemistry from the University of Missouri-Rolla.